Question 1

What is autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation is a rare condition that affects the nerves, specifically the axons of peripheral nerves. People with this condition experience changes in the nerves that help control movement and sensation. The condition is noted for a pattern of progressive weakness and wasting (atrophy) in the muscles of the hands and feet as well as mild losses in sensation for feeling position, vibration, pain, and temperature.

In addition to the classic signs of muscle weakness and sensory problems, individuals may also have signs of pyramidal tract involvement, such as increased muscle tone (spasticity) and brisk reflexes (hyperreflexia). In some cases, spasticity and pain are the first symptoms noticed. This combination of features makes it a unique form of Charcot-Marie-Tooth disease type 2.

Question 2

What are the symptoms of autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

Common symptoms include progressive weakening and wasting of the muscles in the hands and feet, mild sensory deficits affecting position, vibration and pain/temperature sensations, and the development of a high-arched foot (pes cavus). There is also involvement of the pyramidal tract, which can lead to spasticity and increased reflexes. Some individuals may notice pain or stiffness as early signs of the condition.

Question 3

What causes autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation is caused by a mutation in the KIF5A gene. This genetic alteration follows an autosomal dominant pattern, meaning that a person with the mutation has a 50% chance of passing it on to each child. Information about other risk factors for this condition is currently limited.

Question 4

How rare is autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation is classified as not well established. The estimated prevalence is approximately Unknown. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 5

How is autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation diagnosed?

Accepted Answer

The condition is typically diagnosed through a combination of clinical evaluation and neurophysiological studies. These studies can reveal reduced or absent muscle and sensory action potentials while maintaining relatively normal nerve conduction speeds. Genetic testing may also be used to identify the KIF5A mutation. Information about additional diagnostic techniques is currently limited.

Question 6

Are there treatments for autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

Information about treatment is currently limited for this condition.

Question 7

Where can I find support for autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

Patient advocacy organizations for autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation include CMT Research Foundation. These organizations can provide information, connect you with other families, and help navigate care. Visit the Support section of this page for full details and contact information.

Question 8

What complications can arise from autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

People with autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation may experience complications such as muscle weakness and atrophy, especially in the hands and feet. Additionally, some individuals may develop spasticity, which can make movement more difficult. Pain and stiffness can also occur, impacting daily activities.

Question 9

How does autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation affect daily life?

Accepted Answer

Daily life for someone with autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation can be challenging due to muscle weakness and sensory deficits. Tasks that require fine motor skills, like buttoning a shirt or writing, may become harder. Some individuals might need assistive devices for walking or other activities as the condition progresses.

Question 10

What is the long-term outlook for someone with autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

The long-term outlook for someone with autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation is generally gradual progression of symptoms. While muscle strength may decline, nerve conduction velocities tend to remain relatively normal. Quality of life can vary widely depending on the severity of symptoms and how quickly they progress.

Question 11

Are there specific symptoms that are unique to autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Accepted Answer

Yes, autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation has specific symptoms like high-arched feet (pes cavus) and signs of pyramidal tract involvement, such as increased muscle tone and brisk reflexes. Some individuals may also experience pain or stiffness as early signs, which can be unique to this condition.

Kisho

autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation

Overview

Diagnosis

Prognosis

Research Landscape

Recent Publications

Patient Support

Patient Advocacy Groups

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation

Overview

Diagnosis

Prognosis

Research Landscape

Recent Publications

Patient Support

Patient Advocacy Groups

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

What are the symptoms of autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

What causes autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

How rare is autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

How is autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation diagnosed?

Are there treatments for autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Where can I find support for autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

What complications can arise from autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

How does autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation affect daily life?

What is the long-term outlook for someone with autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?

Are there specific symptoms that are unique to autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation?